All Articles

TMYTEK and Comtech launch new user terminals, including an ultra-efficient passive antenna, to deliver seamless satellite connectivity across all orbits.

A new study crowns Appalachian gas as the lowest-methane in the US, but also points to surprising emission sources like old wells and coal mines.

Swedish fintech Futur posted a record 441 MSEK profit in 2025, leveraging its partner-driven platform to thrive amidst economic uncertainty.

A new development in Miami Gardens partners Italian luxury design with advanced tech, promising equitable housing. But can it deliver on its lofty goals?

The ELIJA Foundation's annual event connects families with experts in self-direction, housing, and employment to forge a path to independence for adults with autism.

Anaergia's SoCal facility is the first to supply renewable gas under a new state law, proving a model for turning organic waste into a key energy source.

Proxy advisor ISS deals a major blow to SNT Holdings' activist campaign, recommending shareholders support SMEC's board in a high-stakes corporate showdown.

China's offshore oil giant CNOOC Limited appoints a seasoned leader from rival CNPC, signaling a strategic shift to navigate ambitious growth and energy transition.

New cardiology guidelines now include DNA risk scores, a move poised to revolutionize prevention and spot hidden threats before they strike.

A global police operation dismantled a 373,000-site fraudulent dark web network after advanced analytics traced crypto payments to a single operator.

With 1 million cars on the road, QCraft's CEO argues autonomous vehicles are not the end goal, but the training ground for a new era of physical AI.

With six top honors at a key summit, Fortis Healthcare highlights India's rapid growth as a trusted, affordable destination for advanced medical treatment.

A landmark UN declaration recognizes oral health as a global priority. Now, health advocates are pushing governments to turn promises into patient care.

Egide Group centralizes its US manufacturing in Maryland, closing its California site in a strategic move to boost efficiency and sharpen its competitive edge.

Tescan's new Seoul demo lab is a strategic move to support South Korea's dominance in AI memory and advanced packaging amid a global chip war.

A new oral Alzheimer's drug shows potential for a lower, more patient-friendly dose, aiming to replace complex infusions with a simple daily pill.

China's major presence at the 2026 London Book Fair reveals a calculated push for global influence, blending cultural diplomacy with savvy commercial strategies.

The pharma giant is acquiring a promising 'best-in-class' PI3Kα inhibitor, SNV4818, in a move to bolster its oncology pipeline and redefine cancer care.

Thomas J. Kent Jr.'s investment firm expands to the tech hub, signaling a strategic play beyond traditional VC and a long-term bet on global innovation.

Biotech firm Ribo Life Science reveals a new platform targeting the kidney, heart, and fat tissue, signaling a major shift for RNA-based medicines.